19.96USD-4.95%Mkt Cap: 206.70M $P/E: —1d ago
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of …
Industry Peers
Diagnostics & Research$201.86BUSDP/E 29.8
$145.10BUSDP/E 39.7
$45.85BUSDP/E 44.2
$45.44BUSDP/E 42.4
$38.64BUSD
$38.44BUSDP/E 27.3
$37.13BUSDP/E 48.1
$35.13BUSDP/E 26.2
$28.78BUSDP/E 34.6
$26.98BUSDP/E 31.4
$23.18BUSDP/E 23.1
$23.12BUSDP/E 25.0
$20.55BUSD
$15.36BUSDP/E 33.9
$13.06BUSDP/E 27.3
$12.46BUSDP/E 53.7
$11.04BUSD
$9.26BUSDP/E 21.6
$5.90BUSDP/E 237.4
$5.68BUSD
$5.21BUSDP/E 44.6
$4.95BUSD
$4.73BUSDP/E 54.8
$3.75BUSDP/E 26.5
$3.54BUSD
$3.09BUSD
$2.08BUSD
$1.93BUSD
$1.83BUSD
$1.64BUSDP/E 41.7
$1.63BUSD
$1.48BUSDP/E 22.4
$1.02BUSDP/E 21.4
$898.56MUSD
$734.89MUSD
$616.40MUSDP/E 40.2
$584.63MUSD
$583.63MUSD
$293.12MUSDP/E 2.9
$292.75MUSD
$152.09MUSD
$139.43MUSD
$97.25MUSD
$102.68MUSD
$89.37MUSDP/E 17.2
$73.19MUSD
$58.55MUSD
$42.32MUSD
$30.71MUSD
$26.61MUSD
$20.94MUSD
$16.60MUSD
$12.04MUSD
$9.95MUSD
$8.70MUSD
$8.87MUSD
$7.73MUSD
$7.43MUSD
$6.69MUSD
$6.06MUSD
$5.06MUSD
$4.47MUSD
$4.44MUSD
$2.95MUSD
$3.29MUSD
$3.18MUSD
$869.0KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
Key Statistics
Company
Market Cap206.70M $
Enterprise Value249.76M $
Revenue (TTM)96.10M $
Gross Profit71.78M $
Net Income (TTM)-35.27M $
Revenue/Share11.80 USD
Last Price19.96 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees334
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-90.73
PEG—
EV/EBITDA-12.70
EV/Revenue2.60
P/S2.15
P/B22.08
EPS (TTM)-3.96
EPS (Forward)-0.22
52W Range
5.26075% of range24.92
52W High24.92 USD
52W Low5.260 USD
Profitability
Gross Margin81.11%
Oper. Margin-25.81%
EBITDA Margin-20.47%
Profit Margin-39.85%
ROE1430.63%
ROA-40.31%
Growth
Revenue Growth42.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.27M $
CapEx (TTM)403.00K $
FCF Margin-14.34%
FCF Yield-6.67%
Net Debt48.00M $
Net Debt/EBITDA-2.44
Balance Sheet
Debt/Equity-29.56
Current Ratio2.82
Quick Ratio2.42
Book Value/Sh0.9040 USD
Cash/Share2.530 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 15, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)30.83 USD
Upside (mean)+54.5%
Target Range26.00 USD – 40.00 USD
$26.00+54.5% to mean$40.00
# Analysts6
Ownership
Shares Out.10.36M
Float4.69M
Insiders40.89%
Institutions39.79%
Short Interest
Short Ratio1.3d
Short % Float1.79%
Short % Out.1.02%
Shares Short105.43K
Short (prev mo.)106.46K
Technical
SMA 5017.20 (+16.1%)
SMA 20011.93 (+67.3%)
Beta0.52
S&P 52W Chg20.25%
Avg Vol (30d)79.32K
Avg Vol (10d)77.44K
Technical Indicators
RSI (14)51.8
MACD1.2688
MACD Signal1.5958
MACD Hist.-0.3270
BB Upper25.67 USD
BB Middle20.40 USD
BB Lower15.13 USD
BB Width51.67%
ATR (14)1.784 USD
Vol Ratio (20d)0.66x